HER2 Advanced or Metastatic Breast Cancer Trial - W2301 Clinical Trial Information

Novartis Clinical Trials and Medical Research Studies Recruiting in the U.S.

Mailing List


	Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only.

Novartis Clinical Trials provides information about research studies recruiting within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S.

Study Description

Screening

Study Centers

Contact/Consent

HER2 Advanced or Metastatic Breast Cancer Trial - W2301

The next step is to see if you (or the participant) meet the basic criteria required for participation in this clinical trial. Please fill out the questionnaire below to see if you (or the participant) may be suitable for the clinical trial. Your answers to these questions are not retained by this system. You must answer the questions below for yourself, or, you must be the legally authorized representative of the potential participant in order to answer the questions on their behalf. If you (or the participant) do not meet the preliminary qualifications, you may search for other clinical trials of interest or sign up to the Mailing List.

Answers to all questions are required to determine if you meet the preliminary qualifications for the study.

1) Participation in a clinical trial will require travel to a study center where the clinical trial is being conducted. How far would you (or the participant) be willing to travel to a study center to participate in this clinical trial? Please note that participation in these clinical trials may require a number of visits to the study center and travel expenses may not be covered.

25 miles 50 miles 100 miles 150 miles Unlimited

2) Please enter your residential postal zip code.

3) Are you a female and at least 18 years of age or older?
Yes
No

4) Have you been diagnosed with HER2 advanced or metastatic breast cancer?
Yes
No

5) Do you have a known resistance to trastuzumab (Herceptin®)?
Yes
No
Not Sure

6) Have you received prior therapy with paclitaxel (Taxol®) or docetaxel (Taxotere®)?
Yes
No
Not Sure

7) Has treatment for your cancer included the use of mTor Inhibitors such as sirolimus (Rapamune®) or temsirolimus (Torisel®)?
Yes
No
Not Sure

8) Has treatment of your cancer included vinca alkaloid treatments, such as vincristine (Oncovin®), or vinblastine (Velban®)?
Yes
No
Not Sure

9) Do you have any known sensitivities to everolimus (Afinitor®), sirolimus (Rapamune®), or temsirolimus (Torisel®)?
Yes
No
Not Sure

10) Do you have a history of central nervous system metastasis?
Yes
No
Not Sure

11) Do you have a history of congestive heart failure, or have you ever suffered a heart attack?
Yes
No
Not Sure

12) Have you been diagnosed with any other cancer within the last 5 years, not including cervical or skin cancer?
Yes
No
Not Sure

13) Are you currently pregnant or breastfeeding?
Yes
No
Not Sure

	Site Map \| Contact Us \| Find a Clinical Trial \| Mailing List \| Clinical Trial FAQs
	Clinical Trials Glossary \| About Informed Consent \| Medical Research Areas
	Clinical Trial Resources \| How to use this website